OSTX
OS Therapies Incorporated
0.8722
-0.04 (-4.48%)
52w low 0.5800
2.25 high
17.5% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | -- | 4.45M | 4.34M | 6.81M | 28.71M | |
| R&D | -- | 3.29M | 3.22M | 2.84M | 16.36M | |
| SG&A | -- | 1.15M | 1.13M | 3.97M | 12.34M | |
| Operating Income | -- | -4.45M | -4.34M | -6.81M | -28.71M | |
| EBITDA | -- | -4.45M | -4.34M | -6.83M | -28.39M | |
| Pretax Income | -- | -6.25M | -7.79M | -8.88M | -28.75M | |
| Net Income | -- | -6.25M | -7.79M | -8.88M | -28.75M | |
| EPS Diluted | -- | -0.32 | -0.38 | -1.28 | -0.98 | |
| Diluted Shares | -- | 20.05M | 20.60M | 6.95M | 29.25M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--